| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $433 | +0.0% |
| Gross Profit | $433 | +0.0% |
| R&D Expense | $168K | +0.0% |
| SG&A Expense | $137K | -47.0% |
| Operating Income | -$232K | +75.6% |
| Net Income | -$236K | +75.5% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13K | -7.0% |
| Current Assets | $91K | -0.8% |
| Total Assets | $91K | -0.8% |
| Current Liabilities | $1.2M | +22.6% |
| Total Liabilities | $1.2M | +22.6% |
| Stockholders' Equity | -$1.1M | -25.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1K | +99.6% |
| Investing Cash Flow | -$9K | +0.0% |